< Back to companies

Emperra® has developed a comprehensive digital diabetes management system, ESYSTA. ESYSTA® provides for the first time a full integration of all product components required to guide and monitor the patients like smart insulin pens (usable with all major insulin brands), blood glucose meter and corresponding CE-marked software like web-based portal and apps. The therapy data can be shared among all stakeholders (patient, physicians, nurses, care givers including relatives). With the increasing acceptance of electronic communication and e-health management among all stakeholders, the ESYSTA® system will decisively contribute to improved treatment and patient guidance. A clinical trial with more than 200 patients has shown a distinct clinical benefit. As a result patients’ compliance and self-empowerment is increasing and positive effects on healthcare cost containment will become evident.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2008
Website
www.emperra.com/de/

Categories

Patient EngagementCare ManagementDigital Health Services
Only accessible to MedStartr community members. Join now

What do you think of Emperra?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now